![FemTech Focus artwork](https://is4-ssl.mzstatic.com/image/thumb/Podcasts123/v4/45/c1/19/45c11996-5c35-71f9-02f6-0984c4597237/mza_10902202456499080144.png/100x100bb.jpg)
Acessa Health, a Uterine Fibroids FemTech Exit - Episode 72
FemTech Focus
English - December 16, 2020 07:00 - 42 minutes - 39.2 MB - ★★★★★ - 51 ratingsEducation Technology femtech health tech wellness womenshealth Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Kim Rodriguez was the President, CEO and Co-Founder of Acessa Health, Inc. who successfully sold to Hologic. Prior to Acessa Health, she served as president & CEO of Halt Medical. Prior to that, senior vice president of the Vascular Intervention business unit at Spectranetics, a publicly-traded cardiovascular company acquired by Royal Philips for $2.2B. Over the course of a 20+ year career in cardiology, radiology, vascular surgery, neurology and women’s health, Kim has been involved in the commercialization of dozens of innovative medtech technologies and M&A transactions. Kim received her Executive MBA at the University of Southern California Marshall School of Business and B.S. in Management from Pepperdine University. We discussed being a FemTech exit, uterine fibroids and hysterectomies.
Check out the Acessa Health at www.acessaprocedure.com
Rate, Review & Subscribe!